‹ ›
MYP_157201
← PREVIOUS NEXT → BACK
Basic Information
SAH-gp41(626-662) B
Antimicrobial
Antiviral
Antiviral ▸ Anti-HIV ▸ Anti-HIV-1
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition
not Standard
37 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
XTWMEWDREINNYTSLIHSLIEESQNQXEKNXQELLE
Physicochemical Analysis
0.00 Da
0.00
0.00
0.00
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0064688 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
The 'X' at position 1 indicates Norleucine,the 'X' at position 28,32 indicates S-2-(4'-pentenyl) alanine. X(28) and X (32) are cross-linked by hydrocarbon stapling
Bio-Activity Profile
Antimicrobial Antiviral
HIV-1 HxB2:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells
0.0045±0.0014 μM
IC50
PaperPubMed PMID: 20660316 PMID20660316 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/20660316/
RECORD: Rec_0108226 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
The 'X' at position 1 indicates Norleucine,the 'X' at position 28,32 indicates S-2-(4'-pentenyl) alanine. X(28) and X (32) are cross-linked by hydrocarbon stapling
Bio-Activity Profile
Antimicrobial Antiviral
HIV-1 YU2:inhibition of virus infection in Cf2Th-CD4-CCR5 cells
1.958±0.259 μM
IC50
PaperPubMed PMID: 20660316 PMID20660316 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/20660316/
RECORD: Rec_0228761 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
unspecified non-canonical residue at 1,28,32
Bio-Activity Profile
Antiviral
HIV-1 YU2
PMID20660316 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/20660316/
RECORD: Rec_0302949 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
The 'X' at position 1 indicates Norleucine,the 'X' at position 28,32 indicates S-2-(4'-pentenyl) alanine. X(28) and X (32) are cross-linked by hydrocarbon stapling
Bio-Activity Profile
Antimicrobial Antiviral
PaperPubMed PMID: 20660316 PMID20660316 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/20660316/
RECORD: Rec_0319176 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
HR2 fusion-inhibitory peptide
32630
Structure & Mods
cyclic peptide architecture [Cyclic]
noncanonical stereochemical modification [Modified]
None
None
The 'X' at position 1 indicates Norleucine,the 'X' at position 28,32 indicates S-2-(4'-pentenyl) alanine. X(28) and X (32) are cross-linked by hydrocarbon stapling.
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 YU2 | Cf2Th-CD4-CCR5 cells
1.958±0.259 μM
IC50
PaperHydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic. | Bird GH, Madani N, Perry AF, Princiotto AM, Supko JG, He X, Gavathiotis E, Sodroski JG, Walensky LD. | Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14093-8. | DOI:10.1073/pnas.1002713107 | PMID:20660316 PMID20660316 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/20660316/
1 2 NEXT LAST
Showing 5 records on this page · Page 1 of 2